A Phoenix doctor weighs in on the potential impact of FDA plans to limit COVID booster access to high-risk groups, raising ...

The FDA picked the LP.8.1 Covid strain for the fall vaccines, fueling concerns that the shots may be limited to only the most ...

Low uptake may reflect barriers—misinformation, access or shifting insurance coverage—not simply waning need.

FDA's new COVID-19 vaccine policy may restrict low-risk individuals' access, pending clinical trials to prove benefits.

The FDA will limit the vaccine’s availability later this year to older adults and those who may be at risk of severe illness.

The Trump administration released a 72-page report Thursday outlining its take on what's driving "a chronic disease crisis" ...

Vaccine advisers to the FDA decided Thursday that only strains of the JN.1 variant should be targeted by updated versions of covid vaccines that will be available next fall and winter. Separately, ...

(Reuters) -A class of drugs known as Janus kinase, or JAK, inhibitors, which work by slowing down the immune system, should ...

The advisory committee meeting comes days after the FDA unveiled a new risk-based approval framework for COVID-19 vaccines.

Despite an explanation of the new strategy published Tuesday from FDA Commissioner Marty Makary and Vinay Prasad, who ...

If I am unable to access a vaccine in the future and get a nasty case of COVID, I'll know where to point the finger and so will millions of others.

A government report released on Thursday covering wide swaths of American health and wellness reflects some of the most contentious views on vaccines, the nation’s food supply, pesticides and ...